Antiviral therapy: From influenza to Pfeiffer's disease;Antivirale therapie: Von der grippe bis zum Pfeiffer-drüsenfieber

Internist

Volumn 47, Issue 12, 2006, Pages 1245-1250

  Salzberger, B ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Anitviral chemotherapy; Antiviral substances; Herpes viruses; Resistant viral strains; Respiratory viruses

Indexed keywords

ACICLOVIR; AMANTADINE; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; OSELTAMIVIR; VALACICLOVIR; ZANAMIVIR;

ACROCEPHALOSYNDACTYLY; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DISEASE ASSOCIATION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; MORBIDITY; MORTALITY; REVIEW;

AMANTADINE; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HEPATITIS, VIRAL, HUMAN; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NEURAMINIDASE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 33845907359     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1721-9     Document Type: Review

References (25)

1. Andersson J, Skoldenberg B, Ernberg I et al. (1985) Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study. Scand J Infect Dis [Suppl] 47: 107-115
2. Balfour HH, Hokanson KM, Schacherer RM et al. (2005) A controlled trial of valacyclovir in infectious mononucleosis. In: 45th ICAAC; 2005 December 16-19, 2005. Washington, DC, p V-1392
3. Boeckh M, Gooley TA, Myerson D et al. (1996) Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation - a randomized double-blind study. Blood 88(10): 4063-4071
4. Boeckh M, Fries B, Nichols WG (2004) Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation. Pediatr Transplant 8 [Suppl] 5: 19-27
5. Boeckh M, Kim HW, Flowers ME et al. (2006) Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood 107: 1800-1805
6. Bongartz T, Sutton AJ, Sweeting MJ et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Jama 295: 2275-2285
7. Chou S, Marousek G, Parenti DM et al. (1998) Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis 178(2): 526-530
8. Edwards L, Ferenczy A, Eron L et al. (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human Papilloma Virus. Arch Dermatol 134(1): 25-30
9. Erice A, Borrell N, Li W et al. (1998) Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis 178(2): 531-534
10. Goodrich JM, Bowden RA, Fisher L et al. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118(3): 173-178
11. Jefferson T, Demicheli V, Rivetti D et al. (2006) Antivirals for influenza in healthy adults: systematic review. Lancet 367: 303-313
12. Kaiser L, Wat C, Mills T, Mahoney P et al. (2003) Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163: 1667-1672
13. Kalil AC, Levitsky J, Lyden E et al. (2005) Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 143(12): 870-880
14. Kalil AC, Devetten MP, Singh S et al. (2005) Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis 40(5): 764-766
15. Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353: 369-374
16. Langer-Gould A, Atlas SW, Green AJ et al. (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353: 375-381
17. Limaye AP, Raghu G, Koelle DM et al. (2002) High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 185(1): 20-27
18. Limaye AP, Bakthavatsalam R, Kim HW et al. (2006) Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation 81(12): 1645-1652
19. Machado CM, Boas LS, Mendes AV et al. (2004) Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 34: 111-114
20. McGeer AJ, Green K, Eunson L et al. (2005) Laboratory confirmed Influenza (LCL) requring hospital admission: clinical features, treatment and outcome. In: 45th ICAAC; 2005 December 16-19, 2005. Washington, DC
21. Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39: 1300-1306
22. Oxman MN, Levin MJ, Johnson GR et al. (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352: 2271-2284
23. Syed TA, Hadi SM, Qureshi ZA et al. (2000) Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study. J Infect 41(2): 148-151
24. Willoughby RE Jr, Tieves KS, Hoffman GM et al. (2005) Survival after treatment of rabies with induction of coma. N Engl J Med 352(24): 2508-1514
25. Wutzler P, Kossow K-D, Lode H et al. (2003) Antivirale Therapie und Prophylaxe der Influenza. Chemotherapiejournal 12: 1-3